Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Grant/Award of 22,350 OKUR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 22,350 | n/a |
| Jun 8, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 7,650 | n/a |
| Jun 5, 2026 | MBX Biosciences, Inc. (MBX) | Grant/Award | 12,500 | n/a |
| Jun 4, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 35,000 | n/a |
| Mar 16, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Other (see footnotes) | 4,199 | n/a |
| Mar 13, 2026 | Korro Bio, Inc. (KRRO) | Purchase | 207,100 | $2.30M |
| Mar 4, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Other (see footnotes) | 4,198 | n/a |
| Feb 11, 2026 | SpyGlass Pharma, Inc. (SGP) | Conversion | 1,619,240 | n/a |
| Jan 2, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 3,911 | n/a |
| Oct 6, 2025 | NeueHealth, Inc. (NEUE) | In-the-Money Exercise | 189,195 | $1.9K |